Skip to main content
. 2014 Feb;35(2):379–385. doi: 10.3174/ajnr.A3706

Fig 4.

Fig 4.

Progression-free survival of patients with head and neck squamous cell carcinoma assessed by ΔADC. The graph shows that the median progression-free survival period of patients with ΔADC ≧ 0.24 was significantly longer than that of patients with ΔADC < 0.24 (P < .05).